论文部分内容阅读
目的:观察复方樟柳碱治疗缺血性视神经病变临床疗效。方法:选取收治的缺血性视神经病变患者70例(88眼),随机分成观察组和对照组各35例(44眼),两组患者均给予复方丹参、复方血栓通等传统的扩血管药物治疗,配合维生素、三磷酸腺苷片、肌苷及泼尼松等一般治疗。观察组加用复方樟柳碱注射液患侧颞浅动脉旁注射,1次/d,2 ml/次,14次为1个疗程。结果:连续治疗1～2个疗程后,观察组总有效率明显优于对照组,两组间差异有统计学意义(P<0.05)。结论:复方樟柳碱治疗缺血性视神经病变疗效显著,值得推广。
Objective: To observe the clinical effect of compound anisodine on ischemic optic neuropathy. Methods: Seventy patients (88 eyes) with ischemic optic neuropathy were selected and randomly divided into observation group (35 cases) and control group (44 eyes). Both groups were given traditional vasodilators Treatment, with vitamins, adenosine triphosphate tablets, inosine and prednisone and other general treatment. Observation group plus compound anisodine injection side of the superficial temporal artery injection, 1 / d, 2 ml / time, 14 times for a course of treatment. Results: After continuous treatment of 1 to 2 courses, the total effective rate in the observation group was significantly better than that in the control group, with significant difference between the two groups (P <0.05). Conclusion: Compound anisodine treatment of ischemic optic neuropathy significant effect, it is worth promoting.